<DOC>
	<DOCNO>NCT01965366</DOCNO>
	<brief_summary>Evidence preliminary study suggest people PTSD heighten fear response cortisol suppression reduces heighten fear . Research show drug dexamethasone ( DEX ) , cortisol suppressor , reduce startle response civilian PTSD . This current research proposal represent blind , randomize , placebo-controlled efficacy study goal determine whether drug suppresses stress hormone cortisol increase efficacy exposure therapy . Specifically , propose dose DEX , give night ( approximately 10 hour ) 5 11 individual virtual reality exposure ( VRE ) therapy session , significantly enhance rate response possibly efficacy treatment . Participants treat experience least 70 % reduction PTSD symptom baseline 12 session therapist agree treatment terminate , minimum 6 session maximum 12 session . Comprehensive multi-modal outcome assess independent assessor blind subject condition interview , self-report measure , psychophysiological measure . Participants assess pre- post-treatment follow-up 3 , 6 12 month assess long term effect .</brief_summary>
	<brief_title>Dexamethasone Plus Virtual Reality Exposure Therapy PTSD</brief_title>
	<detailed_description />
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>1 . Participants 60 male female age 21 65 . 2 . Participants must meet DSMV criterion PTSD due exposure trauma serve Operation Iraqi Freedom and/or Operation Enduring FreedomAfghanistan Operation New Dawn . 3 . Patients must literate English . 4 . Patients must medically healthy medically stable stress VR DEX contraindicate . 5 . Participants must comprehend role study risk involve order enter . 1 . Patients history mania , schizophrenia , psychoses ; 2 . Patients prominent suicidal ideation ; 3 . Patients current alcohol drug dependence ; 4 . Patients unable tolerate wear VR helmet ; 5 . Patients unwilling take study medication ; 6 . Patients psychotropic medication ( ) must stable dose least 2 week prior begin study must agree change current medication regimen throughout course study . The concomitant use psychotropic medication record examine data analysis . 7 . Patients special medical condition pregnancy , renal insufficiency , history significant head injury 8 . Active medical disorder contribute psychiatric sx e.g . hypo hyperthyroidism , SLE , advance cirrhosis , etc . ( per clinical judgment study physician ) 9 . Patients stabilize potentially dataobscuring medication ( glucocorticoid ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Virtual Reality</keyword>
	<keyword>Military</keyword>
	<keyword>PTSD</keyword>
</DOC>